ERα-independent NRF2-mediated immunoregulatory activity of tamoxifen
ABSTRACT: Sex differences in immune-mediated diseases are linked to the activity of estrogens on innate immunity cells, including macrophages. Tamoxifen (TAM) is a selective estrogen receptor modulator (SERM) used in estrogen receptor-alpha (ERα)-dependent breast cancers and off-target indications s...
Saved in:
Main Authors: | Giovanna Pepe, Chiara Sfogliarini, Loris Rizzello, Giuseppe Battaglia, Christian Pinna, Gianenrico Rovati, Paolo Ciana, Electra Brunialti, Federica Mornata, Adriana Maggi, Massimo Locati, Elisabetta Vegeto |
---|---|
Format: | article |
Language: | EN |
Published: |
Elsevier
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/a7edf7f586f44f0282507cf6c6d73aa5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Centchroman versus Tamoxifen in the management of mastalgia: a randomized controlled clinical trial
by: S Khadka, et al.
Published: (2016) -
Design and Characterization of Maltoheptaose-<i>b</i>-Polystyrene Nanoparticles, as a Potential New Nanocarrier for Oral Delivery of Tamoxifen
by: Marcos Antonio Villetti, et al.
Published: (2021) -
Breast Cancer and Tamoxifen: A Nigerian Perspective to Effective Personalised Therapy
by: Adehin A, et al.
Published: (2020) -
Comparison of Tamoxifen and Clomiphene on Ovulation and Pregnancy Rates in Polycystic Ovary Syndrome Patients
by: S Esmaeilzadeh,, et al.
Published: (2009) -
Astilbin reduces ROS accumulation and VEGF expression through Nrf2 in psoriasis-like skin disease
by: Wang,Wuyuntana, et al.
Published: (2019)